Grapefruit Juice May Interact with Many Medications, Public Citizen Warns

Drinking grapefruit juice while taking certain medications may be a bad mix, according to a report by the prominent consumer group Public Citizen. 

In the July 2012 issue of Public Citizen’s Worst Pills, Best Pills Newsletter, the group updated warnings about the risk of drug interactions with grapefruit juice, providing a list of 82 medications that may be impacted by the grapefruit juice, resulting in either too much or too little of the drug entering the blood stream.

The report was issued after information was released by the FDA in February 2012, noting new research that found grapefruit juice may decrease the effectiveness of some drugs. Public Citizen had initially warned about the risk of dangerous interactions with grapefruit juice in their Worst Pills, Best Pills Newsletter in February 2004.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Grapefruit juice can interact with many drugs that are broken down (metabolized) with the help of a vital enzyme called CYP3A4 in the small intestine.

Certain substances in grapefruit juice block the action of CYP3A4. Instead of being metabolized, more of the drug enters the bloodstream and stays in the body longer. As a result, users may experience potentially dangerous levels of the drug in your body. Because the CYP3A4 enzyme varies in amounts from one person to another, these problems could affect people differently.

Public Citizen has provided a list of drugs that may interact with, including many widely used medications, such as Lipitor, Tegretol, Propulsid, Celexa, Valium, Benadryl, Multaq, Prozac, Haldol, Serzone, Viracept, Prilosec, Paxil, Seroquel, Zoloft, Viagra, Zocor, Coumadin and others.

The consumer watchdog group has recommended that readers of their newsletter use the U.S. National Library of Medicine’s DailyMed website as a guide for drug interactions and information. DailyMed currently lists product labels for almost 40,000 drugs. The website features the most recent product labels in use and that have been submitted to the FDA for approval.

The group also recommends the following steps to find information concerning grapefruit juice and medications: After accessing the DailyMed website, enter the brand or generic name of the drug you are taking. A list of product labels will appear. Click on the drug you are taking to open the label. Once the label appears on the screen, type in “Ctrl + F” on your key board. Enter “grapefruit juice” into the find function of your Web browser. The term “grapefruit juice” will be highlighted in the document if it is discussed.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted today)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 2 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.